Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1994-10-27
1997-01-14
Weimar, Elizabeth C.
Drug, bio-affecting and body treating compositions
Lymphokine
424 852, 530351, 530399, 530830, 514 8, 514 12, 514 21, A61K 4505, A61K 3800, C07K 100
Patent
active
055936660
ABSTRACT:
A method and composition utilizing thrombopoietin for increasing platelet cell counts in thrombocytopenia is disclosed. The method and composition are suitable for treatments of patients suffering from medical conditions, such as HIV/AIDS or chemotherapy, which result in low platelet cell numbers. Also disclosed are the active moieties or domains of the thrombopoietin molecule.
REFERENCES:
patent: 4894440 (1990-01-01), Rosenberg
patent: 5128449 (1992-07-01), McDonald
patent: 5155211 (1992-10-01), Rosenberg
Lok et al, Nature, vol. 369, pp. 565-567, 16 Jun. 1994.
De Sauvage et al., Nature, vol. 369, pp. 533-538, 16 Jun. 1994.
Carter et al, Radiation Research, vol. 135, pp. 32-39, 1993.
Foster et al, Proc. Natl. Acad. Sci. USA, vol. 91, pp. 13023-13027, Dec. 1994.
Bartley et al, Cell, vol. 77, pp. 1117-1124, Jul. 1, 1994.
Solina et al, FEBS Letters, vol. 353, pp. 57-61, 1994.
De Sauvage et al., Stimulation of Megakaryocytopoiesis and Thrombopoiesis by the c-Mpl Ligand. Nature 1994; 369:533-538.
Lok, et al., Cloning and Expression of Murine Thrombopietin cDNA and Stimulation of Platelet Production in vivo. Nature 1994; 369:565-567.
Kaushansky et al., Promotion of Megakaryocyte Progenitor Expansion and Differentiation by the Ligand Thrombopoietin. Nature 1994; 369:568-570.
Wendling et al., Promotion of Megakaryocyte Progenitor Expansion and Differentiation by the Ligand Thrombopoietin. Nature 1994; 369:571-574.
Sloand EM, Klein HG, Banks SM. Epidemiology of thrombocytopenia in HIV Infection. Eur J Haematol 1992; 48:168-172.
U.S. Department of Health and Human Services. 1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults. Morbid Mortal Weekly Rep 1992; 41/ (RR-17):1-19.
Walsh CM, Nardi MA, Karpetkin S. On the Mechanism of Thrombocytopenic Purpura in Sexually Active Homosexual Men. N Eng J Med 1984; 311:635-639.
Bel-Ali Z, Dufour V, Najean Y. Platelet Kinetics in Human Immunodeficiency Virus Induced Thrombocytopenia. Am J Hematol 1987; 26:299-304.
Zucker-Franklin D, Termin CS, Cooper MC. Structural Changes in the Megakaryocytes of Patients Infected with the Human Immunodeficiency Virus (HIV-1). Am J Pathol 1989; 134:1295-1303.
Scadden DT, Zon LI, Groopman JE. Pathophysiology and Management of HIV-Associated Hematologic Disorders. Blood 1989; 74:1455-1463.
Zucker-Franklin D, Sermetis S, Zheng ZY, Internalization of Human Immunodeficiency Virus Type 1 and Other Retroviruses by Megakaryocytes and Platelets. Blood 1990; 75"1920-1923.
Najean Y, Rain JD. The Mechanism of Thrombocytopenia in Patients with HIV Infection. J Lab Clin Med 1994; 123:415-420.
Jolicoeur P. Murine Acquired Immunodeficiency Syndrome (MAIDS): An Animal Model to Study the AIDS Pathogenesis. FASEB J 1991; 5:2398-2405.
Morse HC, Chattopadhyay SK. Masahiko M, Frederickson TN, Hugin AW, Hartley JW. Retrovirus-Induced Immunodeficiency in the Mouse: MAIDS as a Model for AIDS. AIDS 1992; 6:607-621.
Mosier DE, Yetter RA, Morse HC. Retroviral Induction of Acute Lymphoproliferative Disease and Profound Immunosuppression in Adult C57BL/6 Mice. J Exp Med 1985; 161:766-784.
Chow FPR, Sutton PA, Hamburger AW. 3'-azido-3'-Deoxythymidine Ameliorates the Thrombocytopenia Observed in a Murine Model of AIDS. Exp. Hematol 1990; 18:1038-1041.
Chow FPR, Chen RB, Hamburger AW. Sustained Elevation of Platelet Counts by Long-Term Azidothymidine Treatment of Immunosuppressed Mice. J Lab Clin Med 1993; 121:562-569.
Chow FPR, Ordonez JV, Sutton PA, Hamburger AW. Regulation of Megakaryocyte Colony Forming Cell Numbers and Ploidy by Dideoxynucleosides in Immunodeficient Mice. Am J Hematol 1993; 44:249-255.
McDonald TP, Clift RE, Cottrell MB. A Four-Step Procedure for the Purification of Thrombopoietin. Exp Hematol 1989; 17:865871.
McDonald TP. Bioassay for Thrombopoietin Utilizing Mice in Rebound Thrombocytosis. Proc Soc Exp Biol Med 1973; 144:1006-1012.
McDonald TP. A Comparison of Platelet Size, Platelet Count, and Platelet .sup.35 S incorporation as Assays for Thrombopoietin. Br J Hematol 1976; 34:257-267.
Cullen WC, McDonald TP. Comparison of Sterologic Techniques for the Quantification of Megakaryocyte Size and Number. Exp Hematol 1986; 14:782-788.
Bauer S, Khan A, Klein A, Starasoler L. Naked Megakaryocyte Nuclei as an Indicator of Human Immunodeficiency Virus Infection. Arch Pathol Lab Med 1992; 116:1025-1029.
Levin J, Bessman JD. The Inverse Relation Between Platelet Volume and Platelet Number. J Lab Clin Med 1983; 101:295-307.
McDonald TP, Clift RE, Cottrell MB. Large, Chronic Doses of Erythropoietin cause Thrombocytopenia in Mice. Blood 1992; 80:352-358.
Chow FPR, Zsebo K. Hamburger AW. Effects of in vivo Administration of Stem Cell Factor on Thrombopoiesis in Normal and Immunodeficient Mice. Exp Hematol 1993; 21:1255-1262.
Carter CD and McDonald TP. Thrombopoietin from Human Embryonic Kidney Cells Causes Increased Thrombocytopoiesis in Sublethally Irradiated Mice. Radiat. Res 1992; 132:74-81.
Carter CD, Shultz TW, McDonald TP. Thrombopoietin From Human Embryonic Kidney Cells Stimulates an Increase in Megakaryocyte Size in Sublethally Irradiated Mice. Radiat Res 1993; 135:32-39.
McDonald, TP. Thrombopoietin Its Biology, Clinical Aspects, and Possibilities. The Amer. J. of Ped. Hem./Onc. 1992; 14(1):8-21.
McDonald, et al.. Thrombopoietin from Human Embryonic Kidney Cells is the Same Factor as C-mpl-ligand. Blood 1994 (in press).
Sakaguichi M, Sato T and Groopman JE. Human Immunodeficiency Virus Infection of Megakaryocytic Cells. Blood 1991; 77:481-485.
McDonald TP, Cottrell M, Clift R. Effects of Short-Term Hypoxia on Platelet Counts of Mice. Blood 1978; 51:165-175.
McDonald TP, Cottrell M, Swearingen C, Clift R. Comparative Effects of Thrombopoietin and Interleukin--6 on Murine Megakaryocytopoiesis and Platelet Production. Blood 1991; 77:735-740.
Daniels, III John F.
Mohamed Abdel A.
The University of Tennessee Research Corp.
Weimar Elizabeth C.
LandOfFree
Methods and compositions for treating thrombocytopenia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for treating thrombocytopenia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for treating thrombocytopenia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1386106